BusinessEarth Science Tech, Inc. Targets Breast Cancer and Other Women's Health Issues in New Cannabis CBD-Based Pharmaceutical Drug Development InitiativesBy Nasdaq OMXApr 11, 2017, 11:45 AM UTC
BusinessPeregrine Pharmaceuticals Highlights Clinical Data Presentation at AACR 2017 Annual Meeting Supporting Potential of Bavituximab to Enhance Anti-tumor Activity of ImmunotherapyBy Nasdaq OMXApr 4, 2017, 12:05 PM UTC
BusinessPreclinical Data for Kura Oncology Development Compounds to be Presented at AACR Annual Meeting 2017By Nasdaq OMXMar 29, 2017, 11:33 AM UTC
BusinessGalectin Therapeutics Reports 2016 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 28, 2017, 12:31 PM UTC
BusinessNicolas Barthelemy and Carlos Paya Join Fluidigm Board of DirectorsBy Nasdaq OMXMar 27, 2017, 8:05 PM UTC
BusinessGalectin Therapeutics Issues Statement Regarding GALTW and GALTUBy Nasdaq OMXMar 23, 2017, 12:30 PM UTC
BusinessPeregrine Pharmaceuticals Announces Five Abstracts Accepted for Presentation at AACR 2017 Annual MeetingBy Nasdaq OMXMar 23, 2017, 11:05 AM UTC
BusinessGalectin Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 21, 2017, 12:30 PM UTC
